Related references
Note: Only part of the references are listed.C1q Tumor Necrosis Factor-Related Protein 1: A Promising Therapeutic Target for Atherosclerosis
Zi-Zhen Zhang et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY (2022)
Increased Neutrophil elastase and proteinase 3 are closely associated with occurrence and severity of stroke and acute myocardial infarction in patients with type 2 diabetes mellitus
Lihong Wang et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2022)
Transcriptomic Analysis of the Major Orphan Ichthyosis Subtypes Reveals Shared Immune and Barrier Signatures
Madeline Kim et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2022)
Tape strips from early-onset pediatric atopic dermatitis highlight disease abnormalities in nonlesional skin
Ana B. Pavel et al.
ALLERGY (2021)
Tape strips detect distinct immune and barrier profiles in atopic dermatitis and psoriasis
Helen He et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2021)
The effect and associated mechanism of action of phosphodiesterase 4 (PDE4) inhibitor on CD4+lymphocyte proliferation
Shin Young Kim et al.
CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY (2021)
Mild atopic dermatitis lacks systemic inflammation and shows reduced nonlesional skin abnormalities
Helen He et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2021)
Keratinocytes: innate immune cells in atopic dermatitis
P. Chieosilapatham et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2021)
Microinjection of pruritogens in NGF-sensitized human skin
Hans Juergen Solinski et al.
SCIENTIFIC REPORTS (2021)
JAK inhibitors in the treatment of atopic dermatitis
Raj Chovatiya et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2021)
A phase 2b, randomized, double-blind, multicenter, vehicle-controlled study to assess the efficacy and safety of two crisaborole regimens in Japanese patients aged 2 years and older with mild-to-moderate atopic dermatitis
Kayo Fujita et al.
JOURNAL OF DERMATOLOGY (2021)
TCL1A, B Cell Regulation and Tolerance in Renal Transplantation
Francois Brinas et al.
CELLS (2021)
Efficacy and Safety Trends with Continuous, Long-Term Crisaborole Use in Patients Aged ≥ 2 Years with Mild-to-Moderate Atopic Dermatitis
Bob Geng et al.
DERMATOLOGY AND THERAPY (2021)
The proteomic skin profile of moderate-to-severe atopic dermatitis patients shows an inflammatory signature
Ana B. Pavel et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2020)
Safety, Effectiveness, and Pharmacokinetics of Crisaborole in Infants Aged 3 to < 24 Months with Mild-to-Moderate Atopic Dermatitis: A Phase IV Open-Label Study (CrisADe CARE 1)
Joel Schlessinger et al.
AMERICAN JOURNAL OF CLINICAL DERMATOLOGY (2020)
Interleukin (IL)-17/IL-36 axis participates to the crosstalk between endothelial cells and keratinocytes during inflammatory skin responses
Laura Mercurio et al.
PLOS ONE (2020)
Tape-Strip Proteomic Profiling of Atopic Dermatitis on Dupilumab Identifies Minimally Invasive Biomarkers
Helen He et al.
FRONTIERS IN IMMUNOLOGY (2020)
The Unique Molecular Signatures of Contact Dermatitis and Implications for Treatment
Alexandra Leonard et al.
CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY (2019)
Atopic dermatitis in African American patients is TH2/TH22-skewed with TH1/TH17 attenuation
Riana D. Sanyal et al.
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY (2019)
Dupilumab progressively improves systemic and cutaneous abnormalities in patients with atopic dermatitis
Emma Guttman-Yassky et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2019)
The multiple faces of CD5
Erica Burgueno-Bucio et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2019)
The blood proteomic signature of early-onset pediatric atopic dermatitis shows systemic inflammation and is distinct from adult long-standing disease
Patrick M. Brunner et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2019)
Crisaborole and atopic dermatitis skin biomarkers: An intrapatient randomized trial
Robert Bissonnette et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2019)
JAK Inhibitors for Atopic Dermatitis: An Update
Helen He et al.
AMERICAN JOURNAL OF CLINICAL DERMATOLOGY (2019)
Heparin Binding Protein in Adult Heart Surgery
Eero Pesonen et al.
ANNALS OF THORACIC SURGERY (2019)
The role of phosphodiesterase 4 in the pathophysiology of atopic dermatitis and the perspective for its inhibition
Emma Guttman-Yassky et al.
EXPERIMENTAL DERMATOLOGY (2019)
C1q and TNF related protein 1 regulates expression of inflammatory genes in vascular smooth muscle cells
Dough Kim et al.
GENES & GENOMICS (2019)
A Phase 2 Randomized Trial of Apremilast in Patients with Atopic Dermatitis
Eric L. Simpson et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2019)
Early-onset pediatric atopic dermatitis is characterized by TH2/TH17/TH22-centered inflammation and lipid alterations
Patrick M. Brunner et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2018)
New mechanism underlying IL-31-induced atopic dermatitis
Jianghui Meng et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2018)
Attenuated Activation of Homeostatic Glucocorticoid in Keratinocytes Induces Alloknesis via Aberrant Artemin Production
Akira Matsumoto et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2018)
Adipocytokine Involvement in Innate Immune Mechanisms
Paulina Zelechowska et al.
JOURNAL OF INTERFERON AND CYTOKINE RESEARCH (2018)
The immunology of atopic dermatitis and its reversibility with broad-spectrum and targeted therapies
Patrick M. Brunner et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2017)
The atopic dermatitis blood signature is characterized by increases in inflammatory and cardiovascular risk proteins
Patrick M. Brunner et al.
SCIENTIFIC REPORTS (2017)
Mediators of Chronic Pruritus in Atopic Dermatitis: Getting the Itch Out?
Nicholas K. Mollanazar et al.
CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY (2016)
Early-onset pediatric atopic dermatitis is TH2 but also TH17 polarized in skin
Hitokazu Esaki et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2016)
Efficacy and safety of crisaborole ointment, a novel, nonsteroidal phosphodiesterase 4 (PDE4) inhibitor for the topical treatment of atopic dermatitis (AD) in children and adults
Amy S. Paller et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2016)
Efficacy and safety of dupilumab in adults with moderate-to-severe atopic dermatitis inadequately controlled by topical treatments: a randomised, placebo-controlled, dose-ranging phase 2b trial
Diamant Thaci et al.
LANCET (2016)
Use of a proximity extension assay proteomics chip to discover new biomarkers for human atherosclerosis
Lars Lind et al.
ATHEROSCLEROSIS (2015)
Meta-analysis derived atopic dermatitis (MADAD) transcriptome defines a robust AD signature highlighting the involvement of atherosclerosis and lipid metabolism pathways
David A. Ewald et al.
BMC MEDICAL GENOMICS (2015)
Selectins: initiators of leucocyte adhesion and signalling at the vascular wall
Rodger P. McEver
CARDIOVASCULAR RESEARCH (2015)
Alopecia areata profiling shows TH1, TH2, and IL-23 cytokine activation without parallel TH17/TH22 skewing
Mayte Suarez-Farinas et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2015)
RNA sequencing atopic dermatitis transcriptome profiling provides insights into novel disease mechanisms with potential therapeutic implications
Mayte Suarez-Farinas et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2015)
The Asian atopic dermatitis phenotype combines features of atopic dermatitis and psoriasis with increased TH17 polarization
Shinji Noda et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2015)
Identification of novel immune and barrier genes in atopic dermatitis by means of laser capture microdissection
Hitokazu Esaki et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2015)
Apremilast is a selective PDE4 inhibitor with regulatory effects on innate immunity
P. H. Schafer et al.
CELLULAR SIGNALLING (2014)
Cyclosporine in patients with atopic dermatitis modulates activated inflammatory pathways and reverses epidermal pathology
Saakshi Khattri et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2014)
Dupilumab improves the molecular signature in skin of patients with moderate-to-severe atopic dermatitis
Jennifer D. Hamilton et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2014)
Molecular profiling of contact dermatitis skin identifies allergen-dependent differences in immune response
Nikhil Dhingra et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2014)
Guidelines of care for the management of atopic dermatitis Section 2. Management and treatment of atopic dermatitis with topical therapies
Lawrence F. Eichenfield et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2014)
Dupilumab Treatment in Adults with Moderate-to-Severe Atopic Dermatitis
Lisa A. Beck et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Intrinsic atopic dermatitis shows similar TH2 and higher TH17 immune activation compared with extrinsic atopic dermatitis
Mayte Suarez-Farinas et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2013)
Management of Difficult-to-Treat Atopic Dermatitis
Peter D. Arkwright et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE (2013)
Progressive activation of TH2/TH22 cytokines and selective epidermal proteins characterizes acute and chronic atopic dermatitis
Julia K. Gittler et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2012)
Innate Immunity in Atopic Dermatitis
Andreas Wollenberg et al.
CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY (2011)
Integrative Responses to IL-17 and TNF-α in Human Keratinocytes Account for Key Inflammatory Pathogenic Circuits in Psoriasis
Andrea Chiricozzi et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2011)
Apremilast, a cAMP phosphodiesterase-4 inhibitor, demonstrates anti-inflammatory activity in vitro and in a model of psoriasis
P. H. Schafer et al.
BRITISH JOURNAL OF PHARMACOLOGY (2010)
A milieu of regulatory elements in the epidermal differentiation complex syntenic block: implications for atopic dermatitis and psoriasis
Cristina de Guzman Strong et al.
HUMAN MOLECULAR GENETICS (2010)
The Serine Protease Marapsin Is Expressed in Stratified Squamous Epithelia and Is Up-regulated in the Hyperproliferative Epidermis of Psoriasis and Regenerating Wounds
Wei Li et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Innate Immunity and Adipocyte Function: Ligand-specific Activation of Multiple Toll-like Receptors Modulates Cytokine, Adipokine, and Chemokine Secretion in Adipocytes
Andrea Kopp et al.
OBESITY (2009)
Increased expression of carbonic anhydrase II (CA II) in lesional skin of atopic dermatitis: Regulation by Th2 cytokines
Marijke Kamsteeg et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2007)
Differential expression and function of phosphodiesterase 4 (PDE4) subtypes in human primary CD4+ T cells:: Predominant role of PDE4D
Daniel Peter et al.
JOURNAL OF IMMUNOLOGY (2007)
CD43 collaborates with P-selectin glycoprotein ligand-1 to mediate E-selectin-dependent T cell migration into inflamed skin
Masanori Matsumoto et al.
JOURNAL OF IMMUNOLOGY (2007)
Share Paper
